Three questions for Thomas Heldt: Leveraging insights to enable clinical outcomes Thomas Heldt, associate director of IMES, and a core faculty member, describes the impact of his research on clinical outcomes. Jane-Jane Chen: A model scientist who inspires the next generation A research scientist, and internationally recognized authority in the field of blood cell development, reflects on 45 years at MIT. Teen uses pharmacology learned through MIT OpenCourseWare to extract and study medicinal properties of plants Inspired by traditional medicine, 17-year-old Tomás Orellana is on a mission to identify plants that can help treat students’ health issues. Study assesses seizure risk from stimulating the thalamus In animal models, even low stimulation currents can sometimes still cause electrographic seizures, researchers found. Designing better delivery for medical therapies HST MD/PhD student Sayo Eweje seeks to develop new technologies for delivering RNA and protein therapies directly to the body’s cells. Pagination First page « First Previous page Previous Page 1 Page 2 Page 3 Current page 4 Page 5 Page 6 Page 7 … Next page Next Last page Last »
Three questions for Thomas Heldt: Leveraging insights to enable clinical outcomes Thomas Heldt, associate director of IMES, and a core faculty member, describes the impact of his research on clinical outcomes.
Jane-Jane Chen: A model scientist who inspires the next generation A research scientist, and internationally recognized authority in the field of blood cell development, reflects on 45 years at MIT.
Teen uses pharmacology learned through MIT OpenCourseWare to extract and study medicinal properties of plants Inspired by traditional medicine, 17-year-old Tomás Orellana is on a mission to identify plants that can help treat students’ health issues.
Study assesses seizure risk from stimulating the thalamus In animal models, even low stimulation currents can sometimes still cause electrographic seizures, researchers found.
Designing better delivery for medical therapies HST MD/PhD student Sayo Eweje seeks to develop new technologies for delivering RNA and protein therapies directly to the body’s cells.
